SampleFacts
PrivateLast Round
Grant
Jan 15, 2026
Company Overview
SampleFacts is a biotechnology company that has developed a blood sampling card technology intended to collect blood from dried blood spots.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SampleFacts Comps
Public and private peers based on sector, stage, and business model.
SampleFacts Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 15, 2026 | ||||
| VC Round | May 9, 2025 | ||||
| Seed | Jun 20, 2023 |
Key People
Founding team and executive leadership
SampleFacts Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nordic Science Investments | VC Round |
| Life Science Invest | VC Round |
| Vinnova | Grant |
| Uppsala University Invest | Seed, VC Round |
| STOAF III SciTech | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2026
$14K grant received from Vinnova.
- May 9, 2025
$1.8M round led by Nordic Science Investments and STOAF III SciTech.
SampleFacts Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SampleFacts's valuation, stock price, and market status.
